Specifically, miR-655 was markedly decreased in ovarian cancer tissues, and enhancement of miR-655 levels could suppress cell proliferation and invasive ability of SKOV3 cells by directly targeting RAB1A (33). Here, RAB1A is linked to ovarian cancer.